Compare Mutual Funds
Pros | 5Y returns in the top 25% of the category. Lower expense ratio. Beats FD returns for both 3Y & 5Y duration. | Larger AUM within category. Beats FD returns for both 3Y & 5Y duration. | ||
Cons | - | - |
INDMoney rank | 3/8 | 6/8 | ||
Category | Equity, Sector - Healthcare | Equity, Sector - Healthcare | ||
Fund Age | 7 Years 11 Months | 13 Years 5 Months | ||
Fund AUM | ₹2844 Cr | ₹8306 Cr | ||
Min Investment |
|
| ||
Expense Ratio | 0.47% | 0.91% | ||
Exit Load | 1% | 1% | ||
Benchmark Index | BSE Healthcare TR INR | BSE Healthcare TR INR |
No of Holdings | 35 | 39 | ||
Top 5 Holdings |
|
| ||
No of Sectors | 2 | 1 | ||
Top 3 Sectors |
| Health (100%) | ||
Equity % | 99.72% | 99.7% | ||
Debt % | - | - | ||
P/E | 39.46 | 35.73 | ||
P/B | 5.5 | 5.7 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | -4.51% | -5.31% | ||
3-Month Return | -2.77% | -5.06% | ||
6-Month Return | -1.34% | -2.74% | ||
1-Year Return | 5.03% | 2.65% | ||
3-Year Return | 24.61% | 22.59% | ||
5-Year Return | 16.27% | 14.98% |
Sharpe | 1.06 | 1 | ||
Alpha | 0.09 | 0.22 | ||
Beta | 0.99 | 0.9 | ||
Standard Deviation | 16.76 | 15.72 | ||
Information Ratio | -0.06 | -0.47 |
Description | Mirae Asset Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run. | Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Vrijesh Kasera, Tanmay Mehta | Kinjal Desai, Sailesh Raj Bhan, Amber Singhania |

